Principal investigators seeking to buy peptide Selank 5mg online for laboratory experimentation require strict sequence fidelity, mass spectrometry verification, and rigorous endotoxin control. PX1 Research provides analytical-grade Selank 5mg lyophilized powder accompanied by lot-specific Certificates of Analysis (COA) for in vitro and animal models. Manufactured in domestic GMP-compliant facilities, our neuropeptide reagents support reproducible research across neurochemical and immunological signaling pathways.
Principal investigators seeking to buy peptide Selank 5mg online for laboratory experimentation require strict sequence fidelity, mass spectrometry verification, and rigorous endotoxin control. PX1 Research provides analytical-grade Selank 5mg lyophilized powder accompanied by lot-specific Certificates of Analysis (COA) for in vitro and animal models. Manufactured in domestic GMP-compliant facilities, our neuropeptide reagents support reproducible research across neurochemical and immunological signaling pathways.
To buy peptide Selank 5mg online safely and effectively for laboratory applications, research institutions must select suppliers offering verified high-performance liquid chromatography (HPLC) purity ratings exceeding 98%, complete liquid chromatography-mass spectrometry (LC-MS) identity confirmation, and quantitative endotoxin testing (<0.5 EU/mg). Pure Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide derivative of the human immunomodulatory peptide tuftsin, developed specifically for preclinical investigations involving central nervous system modulation and neuro-immune cross-talk.
When procuring reagents for controlled laboratory environments, investigators should ensure that every vial of Selank 5mg originates from ISO 17025-accredited testing workflows, features verifiable lot traceability, and is shipped in temperature-controlled packaging from domestic distribution centers.
Selank is a synthetic regulatory heptapeptide characterized by the amino acid sequence L-Threonyl-L-Lysyl-L-Prolyl-L-Arginyl-L-Prolyl-Glycyl-L-Proline (Thr-Lys-Pro-Arg-Pro-Gly-Pro). It was engineered by elongating the native sequence of tuftsin (Thr-Lys-Pro-Arg)—an endogenous tetrapeptide located within the Fc fragment of human immunoglobulin G (IgG)—by adding a C-terminal Pro-Gly-Pro tripeptide sequence. This structural modification significantly enhances metabolic stability against circulating carboxypeptidases and aminopeptidases, extending its operational half-life during controlled experimental assays.
In physiological and laboratory assays, tuftsin plays a structural role in modulating phagocytic cell activation and immune competence. By attaching the C-terminal Pro-Gly-Pro motif, researchers generated a stable analog capable of crossing biological barriers and interacting with central neural circuits. For studies analyzing native immunoglobulin fragments and structural derivatives, researchers can review our broader catalog of research peptides and regulatory sequences.
Preclinical literature demonstrates that Selank functions primarily as a regulatory modulator within central neurotransmitter networks. In vitro binding studies and rodent brain tissue assays indicate that Selank alters gamma-aminobutyric acid (GABA) receptor dynamics. Unlike classical benzodiazepines, Selank does not bind directly to the primary GABA-A recognition site; rather, in vitro electrophysiological evidence suggests it exerts an allosteric modulatory effect on GABA-A receptor complexes, altering chloride ion conductance and receptor binding affinity for endogenous GABA.
Furthermore, preclinical animal models investigating monoaminergic neurotransmission demonstrate that Selank administration influences serotonin (5-HT) and dopamine metabolism. In rodent cortical and hippocampal tissue homogenates, researchers observed altered rates of 5-hydroxyindoleacetic acid (5-HIAA) accumulation and modified expression of the serotonin transporter (SERT). These neurochemical shifts suggest that Selank modulates monoamine turnover rates without causing receptor down-regulation, providing a novel framework for examining anxiety-like behavior and stress-response pathways in controlled translational models. Further mechanistic reviews are available in our research library.
In addition to classical neurotransmitter systems, preclinical investigations have focused on Selank's capacity to alter gene expression profiles associated with neuroplasticity and neuronal survival. Rodent models exposed to acute and chronic stress paradigms demonstrated rapid changes in the transcript levels of Brain-Derived Neurotrophic Factor (BDNF) within the hippocampus and frontal cortex following Selank administration.
In vitro neural cell culture studies indicate that Selank exposure leads to an upregulation of BDNF mRNA expression and subsequent activation of its primary receptor, tropomyosin receptor kinase B (TrkB). This neurotrophic cascade is linked to altered dendritic spine density, enhanced synaptic plasticity, and altered long-term potentiation (LTP) protocols. Researchers exploring neurotrophic mechanisms often contrast these cellular effects with those of other central nervous system analogs detailed in our research peptides documentation.
Given its origin as a tuftsin derivative, Selank retains significant immunomodulatory activity that is frequently evaluated in neuroimmunology models. Preclinical studies in murine splenocytes and peripheral blood mononuclear cells (PBMCs) show that Selank modulates the expression of both pro-inflammatory and anti-inflammatory cytokines, including Interleukin-6 (IL-6), Interleukin-10 (IL-10), and Interferon-gamma (IFN-gamma).
In vitro gene expression profiling demonstrates that Selank alters the transcriptional activity of genes governing innate and adaptive immune responses. In animal models of systemic inflammatory challenge, Selank administration altered leukocyte migration patterns and restored balanced cytokine secretion profiles. This dual neuro-immunological activity makes the compound a valuable tool for studying the bidirectional communication pathways between the central nervous system and the immune system. Comparative analysis with dedicated immunological research peptides can be explored via our section on tuftsin analogues in immunology.
When designing preclinical protocols for central nervous system modulation, researchers frequently evaluate Selank alongside other synthetic regulatory peptides. Below is a comparative overview of key regulatory research compounds:
• Selank: A heptapeptide derivative of tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro) evaluated primarily for allosteric GABAergic modulation, monoaminergic turnover, BDNF gene expression, and immune-system cross-talk.
• Semax: An ACTH(4-10) analog (Met-Glu-His-Phe-Pro-Gly-Pro) focused predominantly on melanocortin receptor signaling, BDNF/TrkB activation, cerebral blood flow regulation, and nootropic paradigms.
• Epithalon: A synthetic pineal peptide (Ala-Glu-Asp-Gly) studied primarily for telomerase induction, chromatin remodeling, and circadian rhythm regulation rather than direct neurotransmitter receptor interaction.
• BPC-157: A synthetic gastric pentadecapeptide investigated for nitric oxide pathway modulation, VEGFR2 activation, cytoprotection, and gut-brain axis signaling.
Selecting the appropriate compound depends on whether the experimental focus is on GABA/monoamine neurochemistry (Selank), melanocortinergic neuroprotection (Semax), pineal/epigenetic regulation (Epithalon), or tissue repair cascades (BPC-157).
For empirical research to yield reproducible data, peptide reagents must meet strict chemical purity thresholds. Low-grade peptides containing truncated sequences, residual protecting groups, or heavy metal contamination introduce uncontrolled variables that invalidate assay results.
Every lot of Selank 5mg supplied by PX1 Research undergoes stringent analytical verification:
1. High-Performance Liquid Chromatography (HPLC): Confirms chemical purity >98.0%, ensuring the absence of peptide fragments or organic impurities.
2. Liquid Chromatography-Mass Spectrometry (LC-MS): Verifies exact molecular mass (theoretical monoisotopic mass ~751.9 Da) to guarantee correct sequence assembly.
3. Quantitative Endotoxin Testing: Assessed via Limulus Amebocyte Lysate (LAL) assay to confirm endotoxin levels fall below <0.5 EU/mg, protecting cell culture models from lipopolysaccharide-induced inflammatory artifacts.
4. Lot Traceability & Certificate of Analysis: Independent ISO 17025 laboratory COAs are provided with every batch, allowing principal investigators to verify quality metrics prior to experimental reconstitution. Laboratories requiring large volume batches can access dedicated fulfillment via our wholesale portal.
Proper handling and solubilization are critical to maintaining structural integrity and preventing peptide aggregation. Lyophilized Selank 5mg should be reconstituted under aseptic conditions using sterile laboratory diluents such as Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4), depending on experimental requirements.
Reconstitution Steps for In Vitro / Preclinical Use:
1. Allow the lyophilized vial of Selank 5mg to equilibrate to room temperature before opening to minimize condensation uptake.
2. Sanitize the rubber septum with an 70% isopropyl alcohol wipe.
3. Using a sterile syringe, slowly introduce the desired volume of diluent (e.g., 1.0 mL or 2.0 mL of sterile bacteriostatic water) down the inner glass wall of the vial.
4. Allow the diluent to absorb into the lyophilized cake. Gently swirl the vial in a circular motion. Do not shake vigorously, as mechanical shear stress can cause protein denaturation or foam formation.
5. Visually inspect the solution to ensure complete dissolution. High-purity Selank yields a clear, colorless solution devoid of particulate matter.
Lyophilized Selank 5mg exhibits high physical stability when stored under appropriate environmental conditions. Unreconstituted vials should be stored at -20°C for long-term preservation (up to 24 months) or 2°C to 8°C for short-term storage (up to 90 days), protected from direct light exposure.
Once reconstituted into aqueous solution, the peptide is more susceptible to enzymatic and hydrolytic degradation. Reconstituted stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles and stored at -20°C or -80°C. For working solutions stored at 2°C to 8°C, experimental procedures should be completed within 14 to 21 days to prevent degradation. All handling should adhere to standard aseptic laboratory protocols.
Acquiring reliable research compounds requires partnering with suppliers that maintain transparent quality control standards, domestic manufacturing compliance, and expedited logistics. Substandard imports often lack third-party testing and may contain high endotoxin levels or incorrect amino acid sequences.
PX1 Research manufactures all research peptides in US-based GMP-compliant facilities. Orders are processed with same-day shipping (Monday through Friday) from our fulfillment centers in California and Arizona. Every shipment includes full batch documentation, guaranteeing that academic, pharmaceutical, and corporate laboratories receive consistent, analytical-grade compounds for uninterrupted experimental workflows.
What is the molecular sequence and weight of research-grade Selank?
Selank is a synthetic heptapeptide with the primary amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It has a theoretical molecular weight of approximately 751.9 g/mol. PX1 Research confirms sequence integrity and mass fidelity using liquid chromatography-mass spectrometry (LC-MS) for every batch.
What is the primary mechanism of action of Selank in preclinical studies?
In preclinical research models, Selank acts as an allosteric modulator of GABA-A receptors, alters monoamine (serotonin and dopamine) neurotransmitter turnover, upregulates hippocampal Brain-Derived Neurotrophic Factor (BDNF) expression, and modulates peripheral cytokine production.
How does PX1 Research verify the purity of Selank 5mg?
Every lot of PX1 Research Selank 5mg is tested by independent ISO 17025 analytical laboratories using High-Performance Liquid Chromatography (HPLC) to verify >98% chemical purity, Mass Spectrometry (MS) to verify molecular weight, and LAL assays to confirm endotoxin levels below <0.5 EU/mg.
How should lyophilized Selank 5mg be stored upon receipt?
Unreconstituted lyophilized Selank 5mg should be stored at -20°C for long-term storage or 2°C to 8°C for short-term use, protected from light and moisture. Following reconstitution, solutions should be aliquoted and stored at -20°C or colder to maintain stability.
What diluent should be used to reconstitute Selank 5mg for laboratory assays?
Selank 5mg can be reconstituted using sterile Bacteriostatic Water (0.9% benzyl alcohol) for repeated sampling protocols or sterile phosphate-buffered saline (PBS, pH 7.4) for sensitive cell culture and in vitro biochemical assays.
Is Selank 5mg approved for human consumption or therapeutic use?
No. Selank 5mg supplied by PX1 Research is strictly sold as a research chemical for in vitro, cellular, and animal research applications. It is not intended, approved, or formulated for human consumption, therapeutic administration, or diagnostic use.
How does Selank differ from Semax in experimental models?
While both are synthetic regulatory peptides incorporating a C-terminal Pro-Gly-Pro tripeptide motif, Selank is derived from tuftsin and exhibits GABAergic and immunomodulatory properties. Semax is derived from ACTH(4-10) and primary impacts melanocortin receptor systems, vascular regulation, and cognitive focus models.
Where does PX1 Research ship Selank 5mg from?
PX1 Research dispatches all peptide orders from domestic fulfillment facilities in California and Arizona, offering same-day shipping for orders placed Monday through Friday before cut-off times.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.